Page last updated: 2024-10-25

deferoxamine and Cacosmia

deferoxamine has been researched along with Cacosmia in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Derin, S1
Erdogan, S1
Sahan, M1
Azik, MF1
Derin, H1
Topal, Y1
Topal, H1

Other Studies

1 other study available for deferoxamine and Cacosmia

ArticleYear
Olfactory Dysfunction in β Thalassemia Major Patients Treated With Iron-Chelating Agents.
    Ear, nose, & throat journal, 2019, Volume: 98, Issue:8

    Topics: Adolescent; Adult; Age Factors; beta-Thalassemia; Deferoxamine; Female; Ferritins; Hemoglobins; Huma

2019